The adoptive transfer of dendritic cells (DC) genetically modified to express interleukin-4 (IL-4) significantly reduces the onset of diabetes in both normoglycemic and prediabetic nonobese diabetic (NOD) mice. Here, IL4 is linked to diabetes mellitus.